Late cytogenetic and molecular response to interferon-α (IFN-α) in chronic myelogenous leukemia (CML).

被引：0
|
作者：
Nosari, A
Perego, R
Pungolino, E
Cornacchini, G
Gargantini, L
Morra, E
机构：
[1] Niguarda Hosp, Dept Hematol, Milan, Italy
[2] Univ Milan, Inst Gen Pathol, Milan, Italy
[3] Univ Milan, CNR, Ctr Res Cellular Pathol, Milan, Italy
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2587
引用
收藏
页码：627A / 627A
页数：1
相关论文
共 50 条
  • [31] Prolonged time to cytogenetic and molecular response in patients with relapsed chronic myelogenous leukemia (CML) after donor lymphocyte infusion (DLI).
    Alyea, EP
    Canning, C
    Soiffer, RJ
    Ritz, J
    [J]. BLOOD, 1997, 90 (10) : 2442 - 2442
  • [32] CYTOGENETIC RESPONSE IN CHRONIC MYELOCYTIC-LEUKEMIA (CML) USING RECOMBINANT ALPHA-2 INTERFERON (IFN) PLUS HYDROXYUREA (HU)
    GUILHOT, F
    BRIZARD, A
    HURET, JL
    DREYFUS, B
    DESMAREST, MC
    TANZER, J
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 215 - 215
  • [33] ShortTerm ImatinibTherapy Promotes Bone Formation in Patients with Chronic Myelogenous Leukemia (CML) Independent of Cytogenetic Response
    Hoehn, D.
    Medeiros, L.
    Bueso-Ramos, C.
    [J]. MODERN PATHOLOGY, 2011, 24 : 301A - 301A
  • [34] ShortTerm ImatinibTherapy Promotes Bone Formation in Patients with Chronic Myelogenous Leukemia (CML) Independent of Cytogenetic Response
    Hoehn, D.
    Medeiros, L.
    Bueso-Ramos, C.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 301A - 301A
  • [35] Survival advantage with imatinib mesylate therapy in chronic-phase chronic myelogenous leukemia (CML-CP) after IFN-α failure and in late CML-CP, comparison with historical controls
    Kantarjian, H
    O'Brien, S
    Cortes, J
    Giles, F
    Shan, JQ
    Rios, MB
    Faderl, S
    Verstovsek, S
    Garcia-Manero, G
    Wierda, W
    Kornblau, S
    Ferrajoli, A
    Keating, M
    Talpaz, M
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (01) : 68 - 75
  • [36] CYTOGENETIC FINDINGS IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) - A REPORT OF 58 CASES
    DOSIK, H
    VERMA, RS
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1980, 32 (06) : A103 - A103
  • [37] CYTOGENETIC STUDIES IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) - UNDERGOING INTENSIVE TREATMENT
    CARBONE, PP
    WHANG, J
    FREI, E
    [J]. BLOOD, 1964, 24 (06) : 833 - 833
  • [38] Unusual Cytogenetic evolution in CML treated with interferon-α
    F Maloisel
    A Laplace
    F Uettwiller
    B Lioure
    F Oberling
    [J]. Leukemia, 1997, 11 : 893 - 894
  • [39] Systemic sarcoidosis associated with interferon-α treatment for chronic myelogenous leukemia
    Fiorani, C
    Sacchi, S
    Bonacorsi, G
    Cosenza, M
    [J]. HAEMATOLOGICA, 2000, 85 (09) : 1006 - 1007
  • [40] Interferon-α-induced thrombotic microangiopathy in patients with chronic myelogenous leukemia
    Demoulin, Nathalie
    Jadoul, Michel
    [J]. KIDNEY INTERNATIONAL, 2014, 85 (01) : 213 - 214
12345